Literature DB >> 21892654

Rituximab-induced pulmonary disease.

Mortimer B O'Connor, Mohamad Fadri Bin Abdullah, Neil O'Donovan, Mark J Phelan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21892654     DOI： 10.1007/s00296-011-2110-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  2 in total

Review 1.  Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature.

Authors:  Murali Subramanian; R Manjunath; Nalini Kilara; K N Mohan Rao
Journal:  J Cancer Res Ther       Date:  2010 Jul-Sep       Impact factor: 1.805

Review 2.  Rituximab-induced lung disease: A systematic literature review.

Authors:  H Lioté; F Lioté; B Séroussi; C Mayaud; J Cadranel
Journal:  Eur Respir J       Date:  2009-07-16       Impact factor: 16.671
  2 in total
  2 in total

1.  Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis.

Authors:  Valeria Sainz-Prestel; Jesus Hernandez-Perez; Jorge Rojas-Rivera; José María Milicua-Muñoz; Jesus Egido; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2013-09-01

Review 2.  The safety of biologic therapies in RA-associated interstitial lung disease.

Authors:  Meghna Jani; Nik Hirani; Eric L Matteson; William G Dixon
Journal:  Nat Rev Rheumatol       Date:  2013-12-24       Impact factor: 20.543
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.